Supplemental figure 3 from Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast CancerSuzanne E. Wardell, Shunqiang Li, Matthew J. Ellis et al.|Unknown|2023Cited by 0
Supplemental figure 2 from Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast CancerSuzanne E. Wardell, Shunqiang Li, Matthew J. Ellis et al.|Unknown|2023Cited by 0
Supplemental figure 5 from Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast CancerSuzanne E. Wardell, Shunqiang Li, Robert G. Crowder et al.|Unknown|2023Cited by 0
Supplemental figure 1 from Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast CancerSuzanne E. Wardell, Shunqiang Li, Matthew J. Ellis et al.|Unknown|2023Cited by 0
Supplemental figure 5 from Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast CancerSuzanne E. Wardell, Shunqiang Li, Matthew J. Ellis et al.|Unknown|2023Cited by 0